bpc 157 human clinical trial evidence review 2024 BPC-157 - 5MG/10MG The Stable Gastric Pentadecapeptide BPC

Larger RCT outcome data for direct injectable NAD+ remains limited

Isolated allergy cases are reported, with some successfully treated by desensitisation.70 Transient hypokalaemia during initial B 12 treatment in individuals with severe anaemia is usually mild and without clinical consequences.7 Contraindications Preparations containing benzylalcohol are contraindicated for use in children and pregnant women.71 Cyanocobalamin is associated with worsening of visual problems, and is therefore contraindicated in people with the mitochondrial disorder Lebers hereditary optic neuropathy.72 Cyanocobalamin (but not hydroxocobalamin) is also contraindicated in renal insufficiency.73 Tips for safer prescribing Pregnancy and breastfeeding Continued or new B12 therapy of women with deficiency during pregnancy and lactation is mandatory and safe.74 B 12 deficiency increases the risk of adverse pregnancy outcomes, including early pregnancy loss, neural tube defects, pre-eclampsia, preterm birth, and low birth weight,7576 as well as insulin resistance and adiposity.77 It also may lead to neurological complications in newborns, such as hypotonia, failure to thrive, central apnoeas, and seizures.7879 Children Evidence based treatment advice on treatment in children is lacking

Checking kidney and liver function, both of which can raise circulating B12 when impaired

Injections bypass the digestive system, providing faster, more potent results

Am I ready for the plan that makes results more likely

TB-500 has a 2-day half-life and requires 4-6 weeks of consistent dosing at 2-5 mg per week to reach tissue saturation